Comparison Overview
Lilly Oncology

Lilly Oncology
893 S Delaware St, Indianapolis, 46225, US
Last Update: 29/12/2025
Since 1961, Lilly has been dedicated to delivering life-changing medicines for people living with cancer. Our scientists are urgently advancing new discoveries with the goal of transforming some of the most difficult-to-treat cancers into manageable diseases. Our appro...

Takeda
Tokyo, JP
Last Update: 20/05/2026
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things...
Compliance Ranges Comparison

Lilly Oncology







Takeda






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Lilly Oncology in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Takeda in 2026.
Incident History - Lilly Oncology (X = Date, Y = Severity)
Lilly Oncology cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Takeda (X = Date, Y = Severity)
Takeda cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Lilly Oncology

Takeda
FAQ
Latest Global CVEs
Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.
Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.
Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.
Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.
Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.